CAPITAL FUND MANAGEMENT S.A. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,432,614
+52.1%
69,612
+247.5%
0.01%
+25.0%
Q2 2023$941,857
+3.2%
20,031
-7.9%
0.00%0.0%
Q1 2023$913,007
+45.2%
21,759
+32.0%
0.00%0.0%
Q4 2022$628,890
-99.9%
16,489
+47.9%
0.00%
+33.3%
Q3 2022$436,594,000
-60.4%
11,149
-67.4%
0.00%
-70.0%
Q2 2022$1,103,368,000
-41.1%
34,160
-39.6%
0.01%
-33.3%
Q1 2022$1,872,202,000
-42.3%
56,562
-25.9%
0.02%
-34.8%
Q4 2021$3,246,780,000
+11.6%
76,323
+16.2%
0.02%
+4.5%
Q3 2021$2,910,014,000
-3.9%
65,674
+23.2%
0.02%
-8.3%
Q2 2021$3,028,597,000
-36.1%
53,311
-15.8%
0.02%
-53.8%
Q1 2021$4,740,250,000
+410.2%
63,330
+489.7%
0.05%
+477.8%
Q4 2020$929,117,000
+63.1%
10,740
-21.6%
0.01%0.0%
Q2 2020$569,646,000
+122668.5%
13,700
-15.2%
0.01%
+28.6%
Q1 2020$464,000
+125.2%
16,161
+1146.0%
0.01%
+250.0%
Q1 2019$206,000
-42.8%
1,297
-43.6%
0.00%0.0%
Q2 2018$360,000
-28.7%
2,300
-25.0%
0.00%
-33.3%
Q4 2017$505,0003,0650.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders